Navrang Diagnostics Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 2.45 M
as on 02-07-2024
- Paid Up Capital ₹ 2.42 M
as on 02-07-2024
- Company Age 21 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.49 M
as on 02-07-2024
- Satisfied Charges ₹ 11.56 M
as on 02-07-2024
- Revenue -10.60%
(FY 2020)
- Profit 126.96%
(FY 2020)
- Ebitda 535.44%
(FY 2020)
- Net Worth 8.12%
(FY 2020)
- Total Assets -8.93%
(FY 2020)
About Navrang Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.45 M and a paid-up capital of Rs 2.42 M.
The company currently has active open charges totaling ₹2.49 M. The company has closed loans amounting to ₹1.16 Cr, as per Ministry of Corporate Affairs (MCA) records.
Suresh Vemanna and Mavanur Srinivasan serve as directors at the Company.
- CIN/LLPIN
U85199KA2003PTC032196
- Company No.
032196
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jul 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Navrang Diagnostics?
Board Members(2)
Financial Performance and Corporate Structure Insights of Navrang Diagnostics.
Navrang Diagnostics Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 10.6% decrease. The company also saw a substantial improvement in profitability, with a 126.96% increase in profit. The company's net worth moved up by a moderate rise of 8.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Navrang Diagnostics?
In 2019, Navrang Diagnostics had a promoter holding of 48.63% and a public holding of 51.37%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medocs Associates Diagnostic Services Private Limited
Active
20 years 9 months Suresh Vemanna is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Feb 2024 | ₹2.49 M | Open |
Others Creation Date: 13 Apr 2016 | ₹1.84 M | Satisfied |
Syndicate Bank Creation Date: 25 May 2012 | ₹5.19 M | Satisfied |
How Many Employees Work at Navrang Diagnostics?
Unlock and access historical data on people associated with Navrang Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Navrang Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Navrang Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
